A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake.
D000328:Adult; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002850:Chromatography, Gel; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D004361:Drug Tolerance; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology / Q000652:urine*; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects*; D012559:Schizophrenia / Q000652:urine*; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism
D018492:Dopamine Antagonists; D010455:Peptides; D011957:Receptors, Opioid; D010643:Phenoxybenzamine; D012701:Serotonin; D009270:Naloxone; D006220:Haloperidol; D004298:Dopamine